Article Text

PDF
C1 Scarless gene correction in huntington’s disease patient-derived induced pluripotent stem cells
  1. Xiaohong Xu1,
  2. Yilin Tay1,
  3. Yihui Huang1,
  4. Su-In Yoon2,
  5. Bernice Sim1,
  6. Jolene Ooi1,
  7. Kagistia Hana Utami1,
  8. Carola Radulescu1,
  9. Donovan Low3,
  10. Marie Loh1,
  11. Florent Ginhoux3,
  12. George J Augustine2,4,
  13. Mahmoud A Pouladi1,5
  1. 1Translational Laboratory in Genetic Medicine (TLGM), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos, Singapore
  2. 2Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
  3. 3Singapore Immunology Network (SIgN), A*STAR, Singapore
  4. 4Institute of Molecular and Cell Biology, Singapore
  5. 5Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Abstract

Human induced pluripotent stem cells (hiPSCs) derived from Huntington’s disease (HD) patients provide a physiologically relevant cellular platform for disease modelling and drug screening studies. However, hiPSCs reprogramed from different individuals may exhibit variability in differentiation potential and cellular phenotypes that are independent of the HTT mutation due to variations in genetic background. Thus, in order to accurately detect authentic disease phenotypes and subtle alterations in cell function in hiPSC-based models, the establishment of isogenic controls is necessary. Here we report the scarless correction of an HD iPSC line carrying an expansion of 180 CAG repeats using a CRISPR-Cas9 and piggyBac transposon-based homologous recombination approach. Our results suggest that some molecular changes and phenotypes observed in HD hiPSC models compared with non-related healthy controls in fact reflect differences in the genetic background of the respective lines rather than disease-specific mutant HTT effects. Therefore, our study provides an example of scarless correction of hiPSCs from HD patients and also demonstrates the importance of isogenic controls for disease modelling using hiPSCs.

  • Disease modelling
  • human neurons
  • human induced pluripotent stem cells
  • isogenic

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.